SuperworthMoonLake Immunotherapeutics market cap MLTX
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $1B
- Highest close in our data
- $4B
- Sep 2025
MoonLake Immunotherapeutics is worth $1B at the close on Oct 23, 2026, at $11.85 a share.
That is up 65% over the last year and up 581% over five years.
Its highest close in our data was $4B in Sep 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1B | $767.6M | $1.5B | +14% |
| 2025 | $888.3M | $541.5M | $4B | −75% |
| 2024 | $3.5B | $2.5B | $3.9B | −6% |
| 2023 | $3.8B | $437.7M | $3.8B | +821% |
| 2022 | $409.3M | $74.8M | $430M | +180% |
| 2021 | $146.4M | $145.8M | $186.6M | −13% |
| 2020 | $168.3M | $156.6M | $168.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest MoonLake Immunotherapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| MLTXMoonLake Immunotherapeutics | $1B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| ABUSArbutus Biopharma | $831M |
| COLLCollegium Pharmaceutical | $747.5M |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| PAHCPhibro Animal Health | $1.6B |
| CRMDCorMedix | $611.9M |
| ANIPANI Pharmaceuticals | $1.7B |
| ZVRAZevra Therapeutics | $582.6M |
| Peer median | $1.1B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on MoonLake Immunotherapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.